Dialysis Firm Nephroplus Gets 8,50 Crore From Quadria

New Delhi: Singapore-based healthcare-focused PE firm Quadria Capital has announced an investment of $102 million (Rs 850 crore) in NephroPlus, Asia's largest dialysis network. Quadria will acquire a significant minority stake through a combination of a primary investment and purchase of ₹ shares from existing shareholders, a company statement said...

India Poised To Benefit From US Tariff Hikes

Biden plan to levy high tariffs on a host of Chinese products, including electric vehicles (Evs), batteries, and medical supplies.

US President Joe Biden's plan to levy high tariffs on a host of Chinese products, including electric vehicles (EVs), batteries, and medical supplies, will likely benefit Indian exporters, government officials and trade experts believe...

NPPA Revises Ceiling Price Of Coronary Stents In Tune With WPI Growth

The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling prices of coronary stents with effect from the beginning of April, 2024, in tune with the Wholesale Price Index (WPI) change for the year 2023 over the previous year...

Kotak Alt To Invest Rs 400 Crore In Medical Device Maker Biorad Medisys

Kotak Strategic Situations India Fund II (KSSF II) managed by Kotak Alternate Asset Managers Limited (Kotak Alt) announced investing up to Rs 400 crore in medical device manufacturer Biorad Medisys. The investment will primarily facilitate a new manufacturing plant setup, debt repayment, and increased working capital...

Medtronic Appoints Mandeep Singh Kumar As Vice President Of Medtronic India

India Medtronic Private Limited on Friday announced the appointment of Mandeep Singh Kumar as the new Vice President and Managing Director of India Medtronic Pvt. Ltd., beginning May 2024....